VACCINATION UPTAKE IN A COHORT OF PATIENTS ON BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (BDMARDS) AT A MELBOURNE PUBLIC HOSPITAL

被引：0
|
作者：
Pourhadi, H. [1 ]
Johnson, A. [1 ]
Foote, A. [1 ]
机构：
[1] Northern Hlth, Rheumatol, Epping, NSW, Australia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
COVID; bDMARD; Vaccination/Immunization;
D O I：
10.1136/annrheumdis-2023-eular.5416
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1812-HPR
引用
收藏
页码：2139 / 2139
页数：1
相关论文
共 50 条
  • [41] An overview of biologic disease-modifying antirheumatic drugs in axial spondyloarthritis and psoriatic arthritis
    So, Anthony
    Inman, Robert Davies
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2018, 32 (03): : 453 - 471
  • [42] The exposure to biologic and targeted synthetic disease-modifying antirheumatic drugs in pregnancy and lactation
    Goralczyk, Alicja
    Kolossa, Katarzyna
    Waszczak-Jeka, Marzena
    Adamczak, Rafal
    Jeka, Slawomir
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2020, 37 (03): : 306 - 312
  • [43] ANNUAL TREATMENT COST OF BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS
    Hosseini, R.
    Brown, L. M.
    Fleming, M.
    Rodriguez-Monguio, R.
    Seoane-Vazquez, E.
    VALUE IN HEALTH, 2024, 27 (06) : S110 - S110
  • [44] Comparative Effectiveness of Tofacitinib, Biologic Drugs and Traditional Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
    Machado, Marina
    Moura, Cristiano
    Behlouli, Hassan
    Curtis, Jeffrey
    Bernatsky, Sasha
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 937 - 938
  • [45] COMPARATIVE EFFECTIVENESS OF TOFACITINIB, BIOLOGIC DRUGS AND TRADITIONAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS
    Moura, C. S.
    Machado, M. A.
    Behlouli, H.
    Curtis, J. R.
    Abrahamowicz, M.
    Bernatsky, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 825 - 826
  • [46] Comparative Effectiveness of Tofacitinib, Biologic Drugs and Traditional Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
    Machado, Marina
    Moura, Cristiano S.
    Behlouli, Hassan
    Curtis, Jeffiey R.
    Bernatsky, Sasha
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [47] Use of disease-modifying antirheumatic drugs in patients with psoriatic arthritis
    Marguerie, L
    Flipo, RM
    Grardel, B
    Beaurain, D
    Duquesnoy, B
    Delcambre, B
    JOINT BONE SPINE, 2002, 69 (03) : 275 - 281
  • [48] METHOTREXATE USE AND THE RISK FOR CARDIOVASCULAR DISEASE AMONG RHEUMATOID PATIENTS INITIATING BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
    Xie, F.
    Chen, L.
    Yun, H.
    Levitan, E.
    Muntner, P.
    Curtis, J. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 145 - 145
  • [49] DISEASE-MODIFYING ANTIRHEUMATIC DRUGS - POTENTIAL EFFECTS IN OLDER PATIENTS
    GARDNER, G
    FURST, DE
    DRUGS & AGING, 1995, 7 (06) : 420 - 437
  • [50] Efficacy of Upadacitinib in Patients with Psoriatic Arthritis Stratified by Number of Prior Biologic Disease-modifying Antirheumatic Drugs
    Philip, Mease
    Apinya, Lertratanakul
    Bruce, Strober
    Shigeyoshi, Tsuji
    Pascal, Richette
    Charlie, Lovan
    Dai, Feng
    Jaclyn, Anderson K.
    Filip, van den Bosch
    SWISS MEDICAL WEEKLY, 2021, 151 : S24 - S24
12345